GHA ~ IGOB131

FAIRFIELD, Calif.Gateway Health Alliances Inc. (GHA) identified new indigenous ingredients for the food and beverage, functional food and dietary supplement markets sourced from West Africa. GHA developed and patented the Irvingia gabonensis seed extract, which is supported by published clinical university studies and has been trademarked as IGOB131.  In addition to owning the rights to U.S. Patent No. 7,537,790, GHA holds several patent-pending applications covering its innovations with Irvingia gabonensis.

Julius Oben, Ph.D., head of the Department of Biochemistry, University of Yaoundé I, Yaoundé, Cameroon, discovered the potential weight loss properties and other health related benefits of Irvingia gabonensis. According to Oben, certain Irvingia gabonensis extracts had hypolipidemic, anti alpha-amylase, anti-inflammatory and gene expression activity, thus reducing the amount of ingested starches that would be absorbed as sugar. Obens findings are backed by published clinical university studies. In a randomized, double blind, placebo-controlled investigation, Irvingia gabonensis was shown to significantly reduce body weight and improve metabolic parameters in overweight humans.